New combo therapy aims to save rectums from surgery in rectal cancer trial
Disease control
Recruiting now
This phase 2 trial is testing a new approach for people with a certain type of locally advanced rectal cancer. The treatment combines short-course radiation (sparing lymph nodes), two chemotherapy drugs (capecitabine and oxaliplatin), and an immunotherapy drug (sintilimab). The g…
Phase: PHASE2 • Sponsor: Jinhua Central Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC